Clinical Trial Update: Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC) [NA]

View source ↗

Summary

This clinical trial investigates using imatinib to convert triple-negative breast cancer into estrogen receptor–positive breast cancer, and the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Breast Cancer, Triple Negative Breast Cancer | NA | Status: RECRUITING